GH1 and Langerhans cell histiocytosis: In cases of acquired non-tumoral GHD resulting from conditions such as severe brain trauma, lymphocytic hypophysitis, sarcoidosis, or Langerhans cell histiocytosis, continuation of GH therapy is indicated, particularly in MPHD (47, 48).